Frequency depends on your baseline, goals, and response
Nevertheless, uncertainty surrounding the safety of this regimen is important to acknowledge, as guidelines or case reports for addressing dural sac ruptures have not been published
Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist proven effective for type 2 diabetes and chronic weight management, while Lipo C refers to unapproved compounded lipotropic injections containing methionine, inositol, choline, and vitamin B12
Most people notice an improvement in energy levels within 24-48 hours, though results may vary
Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics comparison with orlistat (Xenical) Obesity (Silver Spring) 2010;18(1 ): 10815
We also offer private blood testing through our London laboratory partner so you can confirm your B12 levels before beginning treatment and monitor your response over time